Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

 

BNN Market Call

Top three stock picks from Goodreid’s Gordon Reid Add to ...

Gordon Reid is president and CEO of Goodreid Investment Counsel. His focus is U.S. equities.

Top Picks:

CVS Caremark

CVS has some cross-winds that allow for a good entry point into the stock. Short-term competitive pressures and challenges in the front of their stores are masking the longer-term positive catalysts of an aging population and easier access to prescription medication because of health care reform.

More Related to this Story

Ensco plc CL A

The youngest fleet in the industry will help this deep-water driller expand profit margins over the coming years. In the meantime, day rates are expanding and utilization rates are high, allowing ESV to grow revenues and earnings briskly.

TeleTech Holdings

TTEC is involved in business process outsourcing and customer relationship management around the world. Goodreid expects ramp-ups of new customer relationships to be lumpy but ongoing leading to solid long-term growth of revenues and earnings.

Past Picks: December 19, 2012 (* all figures US$)

Apple
Then: $526.31
Now: $564.53
Total return: +9.95 per cent

United Therapeutics
Then: $51.49
Now: $93.39
Total return: +81.38 per cent

Walgreen
Then: $37.24
Now: $58.72
Total return: +61.46 per cent

Total return average: +50.93 per cent

Market outlook:

While most of the credit for the equity market rally is going to the Fed’s low interest rate policy, little attention is being paid to corporate earnings, which are the foundation of the market’s current level. The S&P 500 index 2014 weighted earnings estimate is currently $120 per share, up sharply from an inflation-adjusted level $74/share ten years ago and $52/share twenty-five years ago.

Follow us on Twitter: @GlobeInvestor

In the know

Most popular video »

Highlights

More from The Globe and Mail

Most Popular Stories